Description
Cefuroxim (Cefuroxime) Powder for Injections 0.75 g. №1 Vial
Composition
The active ingredient in this product is Cefuroxime, a second-generation cephalosporin antibiotic. Each vial contains 0.75 g of Cefuroxime.
Mechanism of Action
Cefuroxime exerts its bactericidal effect by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs).
Pharmacological Properties
Cefuroxime demonstrates broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It shows stability against beta-lactamases, enhancing its efficacy.
Indications for Use
Cefuroxime is indicated for the treatment of various bacterial infections, including:
- Respiratory tract infections
- Skin and soft tissue infections
- Urinary tract infections
- Septicemia
- Meningitis
Contraindications
Avoid using Cefuroxime if you have a known allergy to Cefuroxime or other cephalosporin antibiotics. It is contraindicated in individuals with severe renal impairment due to the risk of accumulation and toxicity.
Side Effects
Common side effects of Cefuroxime may include gastrointestinal disturbances, allergic reactions, and superinfection. Serious adverse effects like anaphylaxis and pseudomembranous colitis are rare but possible.
Usage Instructions
Cefuroxime is administered via intravenous or intramuscular routes after reconstitution with a compatible diluent. Dosage and administration frequency should be determined by the treating physician based on the specific infection and patient factors.
Benefits Compared to Analogues
Cefuroxime offers a broader spectrum of activity compared to first-generation cephalosporins and demonstrates increased stability against beta-lactamases, reducing the likelihood of resistance development.
Suitable Patient Groups
Cefuroxime can be used in pediatric and adult populations, including elderly patients. Dosing adjustments may be necessary in individuals with renal impairment to prevent drug accumulation.
Storage and Shelf Life
Store Cefuroxime powder for injections according to the manufacturer’s instructions. Avoid exposure to excessive heat or moisture. Check the expiration date on the packaging and do not use the product beyond this date.
Packaging Description
The product is supplied as a single-use vial containing 0.75 g of Cefuroxime powder for reconstitution. Each vial is labeled with the necessary instructions for proper administration.
